Table 2.
Sociodemographic and medical characteristics of the patient sample.
| Total | Age group 40–59 years | Age group 60–79 years | Age group 80–96 years | Age group comparison | ||
|---|---|---|---|---|---|---|
| p | χ2 | |||||
| n | 750 | 83 | 400 | 242 | ||
| Age | 73.3 ± 10.3 | 54.63 ± 3.9 | 70.6 ± 5.5 | 84.1 ± 3.4 | ||
| Sex | 32.8%♀ | 22.4%♀ | 28.0%♀ | 44.1%♀ | <0.001 | 20.49 |
| Occupation | <0.001 | 309.72 | ||||
| Working | 14.2% | 78.3% | 9.0% | 0.4% | ||
| Unemployed | 2.6% | 13.3% | 2.0% | 0.0% | ||
| Retired | 83.3% | 8.4% | 89.0% | 99.6% | ||
| Education | 0.005 | 14.48 | ||||
| Primary | 3.5% | 1.2% | 3.1% | 4.3% | ||
| Secondary | 78.1% | 89.2% | 80.6% | 70.7% | ||
| Tertiary | 18.4% | 9.6% | 16.4% | 25.0% | ||
| Area | <0.001 | 24.00 | ||||
| City | 23.8% | 16.5% | 19.5% | 32.2% | ||
| Small town | 26.8% | 17.7% | 28.7% | 28.3% | ||
| Rural | 49.4% | 65.8% | 51.8% | 39.6% | ||
| Living alone | 22.0% | 18.1% | 17.0% | 31.4% | <0.001 | 19.09 |
| Care level | 16.5% | 6.5% | 9.8% | 30.3% | <0.001 | 47.14 |
| CAD symptoms (CCSA) | 0.158 | 9.30 | ||||
| Grade I | 58.6% | 57.7% | 61.1% | 54.3% | ||
| Grade II | 12.6% | 11.5% | 12.8% | 12.6% | ||
| Grade III | 17.1% | 15.4% | 13.9% | 22.9% | ||
| Grade IV | 11.7% | 15.4% | 12.3% | 10.3% | ||
| CAD risk stratification | 0.330 | 2.22 | ||||
| Low risk | 92.4% | 88.5% | 93.1% | 93.3% | ||
| High risk | 7.6% | 11.5% | 6.9% | 6.7% | ||
| COVID-19 infection | 0.8% | 1.2% | 1.3% | 0.0% | 0.163 | 3.32 |
| Other chronic diseases | ||||||
| Asthma | 6.1% | 4.8% | 7.0% | 5.4% | 0.714 | 0.81 |
| Breast cancer | 3.3% | 1.2% | 3.0% | 4.5% | 0.387 | 2.08 |
| COPD | 7.7% | 2.4% | 9.5% | 6.2% | 0.052 | 5.91 |
| Type 1 DM | 2.1% | 3.6% | 2.3% | 1.7% | 0.536 | 1.34 |
| Type 2 DM | 27.4% | 9.6% | 29.3% | 29.0% | 0.001 | 14.25 |
Data are presented as mean, standard deviations, and percentage (n/nvalid). Age was not available for 25 patients. CAD, coronary artery disease; CCSA, Canadian Cardiovascular Society Angina Classification; COPD, Chronic obstructive pulmonary disease; DM, Diabetes mellitus. The bold p-values highlight a significant result.